Unithiol
- done All payments are SSL encrypted
- done Full Refund if you haven't received your order
- done International shipping to the USA, UK and Europe
Clinical Pharmacology
Unithiol - complexing agent, has a detoxification effect.
The active sulfhydryl groups of Unithiol, interacting with thiol poisons (arsenic compounds, salts of heavy metals) and forming non-toxic water-soluble compounds with them, restore the functions of the enzyme systems of the body affected by poison.
Increases the elimination of certain cations (especially copper and zinc) from metal-containing cell enzymes.
Pharmacokinetics
When administered parenterally rapidly absorbed into the blood. The maximum concentration of the drug in the blood (Cmax) is achieved in 15-30 minutes after intramuscular injection.
The half-life (T1 / 2) is 1-2 hours.
The volume of distribution is 166.5 ml / kg. The drug is distributed mainly in the aqueous phase (blood plasma). Not cumulated.
Excreted by the kidneys, mainly in the form of products of incomplete and complete oxidation, partially in unchanged form.
Indications
- intoxication with arsenic, mercury, bismuth, chromium, cardiac glycosides;
- hepatocerebral dystrophy (Wilson-Westfal-Konovalov disease);
- chronic alcoholism (as part of complex therapy),
- delirium tremens.
Composition
1 ml solution for intramuscular and subcutaneous administration contains:
active ingredients: sodium dimercaptopropanesulfonate monohydrate (unithiol) 50 mg;
excipients: disodium edetate (Trilon B), sulfuric acid 0.1 M (to pH 3.1-4.5), water d / u.
No customer reviews for the moment.
Dosage and Administration
Unithiol is used primarily intramuscularly or subcutaneously.
- When arsenic intoxication - 5-10 ml of the drug (at the rate of 0.005 g / 1 kg), in 1 day - 3-4 times, in 2 days - 2-3 times, the next - 1-2 times.
- In case of poisoning with mercury compounds - in the same pattern for 6-7 days. The treatment is carried out until the disappearance of signs of intoxication.
- In case of digitalis intoxication, in the first 2 days, 5-10 ml of a 5% aqueous solution is injected 3-4 times / day, then 1-2 times / day until the cardiotoxic effect ceases.
- When hepatocerebral dystrophy - in / m 5-10 ml of 5% solution daily or every other day; a course of treatment is 25-30 injections; If necessary, repeat after 3-4 months.
- In chronic alcoholism, 3-5 ml is prescribed 2-3 times a week.
- For the relief of delirium - once 4-5 ml.
Adverse reactions
- nausea,
- dizziness,
- tachycardia,
- paleness of the skin,
- allergic reactions are possible.
Contraindications
- hypersensitivity to the drug Unithiol,
- liver failure,
- arterial hypertension,
- children's age up to 18 years.
Drug interactions
The simultaneous use of Unithiol with drugs that include heavy metals and alkalis is not recommended, as Uniol is rapidly decomposed.
Pregnancy and Lactation
Contraindicated in pregnancy and lactation.
Special instructions
In case of acute poisoning, additional therapeutic measures are performed (gastric lavage, oxygen therapy, administration of dextrose, etc.).
Overdosage
Symptoms: shortness of breath, hyperkinesis, lethargy, lethargy, stupor, short-term seizures (occur when the recommended therapeutic dose is exceeded by more than 10 times).
Treatment: symptomatic therapy.
- Brand name: Unithiol
- Active ingredient: Sodium Dimercaptopropanesulfonate
- Dosage form: Solution for intramuscular and subcutaneous administration
- Manufacturer: Yerevan HFF
- Country of Origin: Armenia
Studies and clinical trials of Unithiol (Click to expand)
- Complex of technetium(V) with 2,3-dimercaptopropansulphonate (unithiol): Preparation and distribution in the rat
- Action of unithiol and cysteine on the renal effect of strophanthin
- Neutralization of the toxic action of endotoxins of gram-negative bacteria by unithiol and magnesium sulfate
- Effect of unithiol and acetylcysteine on lipid peroxidation and the erythrocyte antioxidant system of sensitized guinea pigs
- Use of Unithiol for reducing radiation hazard of renal scintigraphy with Chlormerodrin203Hg
- Use of Unithiol for reducing radiation hazard of renal scintigraphy with Chlormerodrin203Hg
- Amperometric detection of unithiol complexes of heavy metals in high-performance liquid chromatography
- IR spectroscopic study of interactions in the acetaldehyde-dopamine-unithiol ternary system
- Electrochemical determination of unithiol and lipoic acid at electrodes modified with carbon nanotubes
- Ion-Pair Chromatography of Metal Complexes of Unithiol in the Presence of Quaternary Phosphonium Salts
- Die Verwendung von Natrium-2,3-dimercaptopropansulfonat („Unithiol“) (I) zur volumetrischen Bestimmung von Zink
- Unithiol (2,3-Dimercaptopropansulfonat Natriumsalz) (I), das mit einer Reihe zweiwertiger Schwermetallionen stabile Chelate bildet
- Die polarographische Reduktion von Unithiol
- Reaction of dehydroascorbic acid with unithiol and some of its kinetic regularities
- Influence of unithiol, d-penicillamine, and cysteine on the biological effects of bradykinin and the activity of carboxypeptidase N and peptidyl dipeptidase
- Utilization of lead chloride —A by-product of unithiol production
- An electrochemical method of production of sodium 2,3-dibromopropanesulfonate in unithiol manufacture
- Unithiol as a reagent for molybdenum
- Effect of unithiol on acute adriamycin cardiotoxicity in rat
- Sorption preconcentration of cadmium and lead ions as complexes with unithiol on a silica surface modified by quaternary ammonium salt groups
- Unithiol
- Unithiol
- Unithiol
- Comparative IR Spectroscopic Study of the Effects of Unithiol and its Disulfide Derivatives on the Reaction Between Acetaldehyde and Dopamine